LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Book: Optimal treatment of chronic constipation in managed care

    Eoff, James C. / Lembo, Anthony J.

    review and roundtable discussion

    (Journal of managed care pharmacy ; 14,9-a = Suppl.)

    2008  

    Author's details James C. Eoff and Anthony J. Lembo
    Series title Journal of managed care pharmacy ; 14,9-a = Suppl.
    Collection
    Language English
    Size S17 S. : graph. Darst.
    Publisher Acad. of Managed Care Pharmacy
    Publishing place Alexandria, VA
    Publishing country United States
    Document type Book
    HBZ-ID HT015784698
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    Zs A 5450 -14,9-a- not available for loan Zeitschriften-Lesesaal

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article: Optimal treatment of chronic constipation in managed care: review and roundtable discussion.

    Eoff, James C

    Journal of managed care pharmacy : JMCP

    2008  Volume 14, Issue 9 Suppl A, Page(s) 1–15

    Abstract: ... constipation; (b) describe how chronic constipation impacts quality of life; and (c) describe how all providers ...

    Abstract Background: Prevalence studies estimate that chronic constipation affects 12%-19% of Americans. This prevalence rate exceeds that of many highly publicized chronic conditions, including diabetes and asthma. Identifying the etiology of each patient's constipation is essential for determining treatment and management plans. The etiology of chronic constipation falls into 2 broad categories: primary or idiopathic constipation caused by physical and functional problems, and secondary constipation resulting from a variety of organic conditions as well as the use of certain medications. Patients may have more than one cause of their constipation. Treatment options may be based not only on the cause but may be dictated by a patient's health care coverage and the inclusion criteria of different health care plans.
    Objectives: To (a) present key information on the causes, diagnosis, and treatment recommendations for patients with chronic constipation; (b) describe how chronic constipation impacts quality of life; and (c) describe how all providers can work to improve the quality of care and health outcomes for patients with chronic constipation.
    Summary: Chronic constipation is a prevalent condition that disproportionately affects women and the elderly. Most agents are available over-the-counter, although their efficacy has not been extensively tested. Few prescription agents are currently available, and they are more costly; therefore, managed care plans may restrict these products for patients who fail traditional treatments. A lack of evidence-based algorithms leaves many providers to treat patients empirically. Practitioners can assist patients seeking recommendations and provide information on treatment options.
    MeSH term(s) Age Factors ; Aged ; Chronic Disease ; Constipation/drug therapy ; Constipation/economics ; Constipation/etiology ; Female ; Humans ; Male ; Managed Care Programs/economics ; Managed Care Programs/standards ; Quality Assurance, Health Care/methods ; Quality of Life ; Sex Factors ; Treatment Outcome ; United States/epidemiology
    Language English
    Publishing date 2008-06-18
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2022394-8
    ISSN 1944-706X ; 1083-4087
    ISSN (online) 1944-706X
    ISSN 1083-4087
    DOI 10.18553/jmcp.2008.14.S8-A.1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 5450: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Article: Impact of Medicare Part D on Racial and Ethnic Minorities.

    Jamison, JoEllen Jarrett / Wang, Junling / Surbhi, Satya / Adams, Samantha / Solomon, David / Hohmeier, Kenneth C / McDonough, Sharon / Eoff, James C

    Diversity and equality in health and care

    2016  Volume 13, Issue 5, Page(s) 326–333

    Abstract: Objectives: Prior to the implementation of Medicare Part D in the United States, inequalities were found to exist in the use of medications between minority and white beneficiaries. Despite improvements in medication affordability after Medicare Part D ... ...

    Abstract Objectives: Prior to the implementation of Medicare Part D in the United States, inequalities were found to exist in the use of medications between minority and white beneficiaries. Despite improvements in medication affordability after Medicare Part D implementation, it is still not clear whether the characteristics of the program have improved drug utilization patterns among minorities to the same degree as whites. This review aims to determine whether there were barriers for Medicare Part D to realize its potential to improve prescription drug utilization patterns among minorities.
    Methods: Google Scholar, PubMed, Sciencedirect and Scopus were used to conduct a comprehensive search of the literature published since 2003 when the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) was passed, which authorized the establishment of the Part D program. All studies and documents related to the effects of Medicare Part D on minorities were included to present a relatively comprehensive review on the topic.
    Results: Evidence indicated that minorities are not equally benefiting from Medicare Part D prescription drug coverage compared to whites. Examples of characteristics of Medicare Part D that caused significant racial differences in drug utilization include the donut hole, the complexity and number of drug plans, and drug utilization management strategies.
    Conclusion: Medicare Part D has increased access to prescription medications for the elderly. However, continued analysis and research of drug utilization patterns among minorities should be conducted to ensure that all enrollees regardless of race are benefiting equally from Medicare Part D. Identification of these barriers can provide insights on how to improve the program to allow minorities to benefit equally from the Medicare Part D program and remove health inequalities.
    Language English
    Publishing date 2016-08-23
    Publishing country England
    Document type Journal Article
    ISSN 2049-5471
    ISSN 2049-5471
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

To top